首页> 外国专利> METHOD FOR EVALUATING HEALTH STATE AND METHOD FOR PREDICTING LONG-TERM EFFICACY OF ANTICANCER AGENT

METHOD FOR EVALUATING HEALTH STATE AND METHOD FOR PREDICTING LONG-TERM EFFICACY OF ANTICANCER AGENT

机译:评估健康状况的方法和预测抗癌剂长期有效性的方法

摘要

A method for evaluating health state that comprises: measuring the amount of cell-free DNA per unit amount of a body fluid sample collected from a subject after tumor removal; comparing the amount of cell-free DNA measured above to a standard value to thereby evaluate the health state of the subject; said standard value being any one of a preset threshold, the amount of cell-free DNA per unit amount of a body fluid sample collected from the aforesaid subject prior to the tumor removal, the amount of cell-free DNA per unit amount of a body fluid sample collected from the aforesaid subject one week to three months after the tumor removal, and the amount of cell-free DNA per unit amount of a body fluid sample collected from the aforesaid subject prior to the collection of the aforesaid body fluid sample; and, in the evaluation of the health state of the subject, when the measured amount of cell-free DNA is larger than the standard amount, it is evaluated that a tumor nest is enlarged or highly possibly enlarged in the subject, new metastasis occurs or highly possibly occurs in the subject, or the health state of the subject worsens or highly possibly worsens though neither tumor nest enlargement nor new metastasis occurs.
机译:一种评估健康状况的方法,包括:测量除去肿瘤后从受试者收集的每单位量体液样品中无细胞DNA的量;将以上测量的无细胞DNA的量与标准值进行比较,从而评估受试者的健康状况;所述标准值是预设阈值中的任意一个,即在去除肿瘤之前从前述受试者收集的每单位量的体液样品中的无细胞DNA的量,每单位量的身体中的无细胞DNA的量。在去除肿瘤后一星期至三个月从上述受试者收集的体液样品,以及在收集上述体液样品之前从上述受试者收集的每单位量体液样品中的无细胞DNA的量;并且,在评价受试者的健康状况时,当测定的无细胞DNA量大于标准量时,评价为肿瘤巢增大或极有可能增大,发生新的转移或尽管既不发生肿瘤巢增大也不发生新的转移,但是很可能在受试者中发生,或者受试者的健康状况恶化或非常可能恶化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号